Physician profile

Babu Jasti

Interventional Cardiology · Zachary, LA

NPI 1417983271

$4,472.39

in general payments reported to CMS, 2019-2025

31 companies · $395 in 2025

The $395 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,159.99
Education$20.22

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Janssen Pharmaceuticals, INC $653.78 2019-2024 Xarelto
Novartis Pharmaceuticals Corporation $564.92 2019-2025
Angiodynamics, INC. $464.21 2023-2024 Auryon Laser System 100-120 Vac, Alphavac
Amgen INC. $406.53 2019-2024 Repatha
Pfizer INC. $308.64 2019-2024
Abbott Laboratories $235.78 2020-2024 Pressurewire
Boston Scientific Corporation $172.74 2019-2025 General - Balloon Catheters, Opticross, Watchman
Astrazeneca Pharmaceuticals LP $140.37 2019-2025 Farxiga
Medtronic, INC. $126.02 2023-2025 Corevalve Evolut R, Aquamantys(Tm), Plasmablade(Tm)
Esperion Therapeutics, INC. $125.94 2020-2024 Nexletol
Cleerly, INC. $120.40 2025 Cleerly Ischemia, Cleerly Labs
Zoll Circulation INC $119.14 2023 Downstream Cartridge, Catheter, Therox Ds2 Console
Boehringer Ingelheim Pharmaceuticals, INC. $116.02 2022-2025 Jardiance
Astellas Pharma US INC $105.35 2019
Silk Road Medical, INC. $94.74 2021
Show all 31 companies
CompanyGeneral paymentsYearsTop products
Merck Sharp & Dohme LLC $91.87 2021-2023 Verquvo
Philips North America LLC $91.30 2019-2021
Lexicon Pharmaceuticals, INC. $82.14 2023-2024 Inpefa
Novo Nordisk INC $82.00 2021-2024 Rybelsus, Ozempic, Wegovy
Cvrx, INC. $60.31 2023 Barostim Neo System
Bayer Healthcare Pharmaceuticals INC. $51.95 2021-2025
Cardiac Dimensions, INC. $50.81 2025
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $44.33 2023 Lifevest
E.R. Squibb & Sons, L.L.C. $31.49 2024 Eliquis, Camzyos
Scpharmaceuticals INC. $25.97 2024
Arbor Pharmaceuticals, INC. $24.78 2019
Amarin Pharma, INC. $20.72 2021
Kestra Medical Technology Services, INC. $17.45 2023 Assure Wcd
Regeneron Healthcare Solutions, INC. $17.19 2019
Alexion Pharmaceuticals, INC. $13.78 2021
Gilead Sciences, INC. $11.72 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Babu Jasti

$4,472.39

in general payments reported 2019-2025

Years
2019-2025
Top company
Janssen Pharmaceuticals, INC
Context
The $395 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/336194/babu-jasti

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.